YHR175W-A Antibody

Basic Research Questions

• What is YHR175W-A and what organism is it found in?

YHR175W-A is a gene in Saccharomyces cerevisiae (baker's yeast), specifically identified in the S288c strain. It encodes a small protein that was discovered through fungal homology studies and confirmed through RT-PCR. Despite its identification, the biological role of this protein remains largely undefined. Research suggests potential involvement in stress response or metabolic pathways based on homology to other fungal proteins, though definitive functional characterization is still pending.

• What are the basic physical properties of the YHR175W-A protein?

The YHR175W-A protein consists of 49 amino acids with a molecular weight of 5,709.7 Da (approximately 5.7 kDa) and an isoelectric point (pI) of 9.7, making it a small, basic protein. These properties have important implications for experimental design when using antibodies to detect this protein.

The small size means that high-resolution gels (such as 15% SDS-PAGE) are required for accurate separation during Western blot analysis. The basic pI may affect immunoprecipitation efficiency and should be considered when optimizing extraction conditions.

• What applications has the YHR175W-A antibody been validated for?

The YHR175W-A antibody has been validated for Western blot (WB) and enzyme-linked immunosorbent assay (ELISA) with S. cerevisiae lysates. It shows high sensitivity, capable of detecting YHR175W-A at concentrations as low as 0.1 ng/mL in ELISA. The antibody demonstrates good specificity with no reported cross-reactivity with S. cerevisiae paralogs such as YHR213W-A and YHR214C-E. Researchers use this antibody to explore:

• Subcellular localization (whether cytoplasmic or membrane-bound)

• Expression patterns under varying growth conditions

• Interactions with other yeast proteins

• How should I prepare samples for YHR175W-A detection in Western blots?

For Western blot detection of YHR175W-A, sample preparation requires careful consideration due to the protein's small size (5.7 kDa):

• Use high-resolution gels (15% SDS-PAGE or higher) for accurate separation

• Employ standard lysis buffers containing protease inhibitors to prevent degradation

• Optimize buffer pH considering the protein's basic pI of 9.7

• Select appropriate loading controls (preferably other small proteins rather than larger housekeeping proteins)

• Optimize transfer conditions for small proteins, potentially using PVDF membranes with smaller pore sizes

• Consider shorter transfer times or specialized transfer methods to prevent protein loss

These considerations are critical since small proteins like YHR175W-A can be challenging to detect with standard Western blot protocols designed for larger proteins .

• What are the best quality control measures for YHR175W-A antibody?

Quality control for YHR175W-A antibody should include:

• Batch consistency verification (<10% variability in titer across production lots is reported)

• Sensitivity testing (confirm detection at concentrations as low as 0.1 ng/mL in ELISA)

• Cross-reactivity testing against related proteins, particularly paralogs like YHR213W-A and YHR214C-E

• Validation across multiple applications (WB, ELISA) with appropriate controls

• Documentation of lot numbers and preparation of standard operating procedures for reproducibility

According to antibody validation standards, researchers should independently validate commercially obtained antibodies rather than relying solely on manufacturer data .

Advanced Research Questions

• How can I validate the specificity of YHR175W-A antibody in my experiments?

Validating the specificity of YHR175W-A antibody requires a multi-faceted approach following the International Working Group for Antibody Validation guidelines:

• What is known about the biological function of YHR175W-A protein?

The biological function of YHR175W-A protein remains largely undefined despite its identification through fungal homology studies. Current hypotheses suggest potential involvement in:

• Stress response pathways

• Metabolic regulation

• Protein-protein interactions in cellular signaling

The lack of phenotypic data from YHR175W-A knockout strains complicates functional studies. Researchers are investigating its role through various approaches including:

• Subcellular localization studies

• Expression pattern analysis under different growth conditions

• Protein-protein interaction studies to identify binding partners

• Comparative genomics to identify functional domains conserved across fungal species

Pairing YHR175W-A antibodies with CRISPR-based gene editing or transcriptomic analyses may help elucidate this protein's role in yeast biology.

• How can I optimize immunoprecipitation protocols for YHR175W-A given its small size and basic pI?

Optimizing immunoprecipitation (IP) for YHR175W-A requires special considerations due to its small size (5.7 kDa) and basic pI (9.7):

• Use lysis buffers with pH values slightly below the protein's pI to enhance solubility while maintaining native structure

• Add mild detergents like CHAPS or digitonin that preserve protein-protein interactions

• Cross-link the antibody to beads to prevent antibody co-elution and improve detection of small proteins

• Consider chemical crosslinking agents (like DSP or formaldehyde) to stabilize protein complexes before lysis

• For elution, use acidic glycine buffers (pH 2.5-3.0) rather than reducing agents

• Use high percentage gels (15-20%) for SDS-PAGE separation

• Consider silver staining for enhanced detection sensitivity

As noted in the research literature, "the protein's small size and basic pI may affect immunoprecipitation efficiency", making these optimizations particularly important.

• What approaches can be used to study YHR175W-A function given the lack of phenotypic data from knockout strains?

To study YHR175W-A function despite the lack of phenotypic data from knockout strains, researchers can employ several strategic approaches:

• Generate conditional knockdowns or auxin-inducible degron (AID) systems for temporal control of protein depletion

• Conduct overexpression studies to observe gain-of-function phenotypes

• Perform systematic stress response assays under various conditions (temperature, pH, osmotic stress, oxidative stress)

• Use synthetic genetic array (SGA) analysis to identify genetic interactions

• Apply ribosome profiling to determine if YHR175W-A affects translation of specific mRNAs

• Perform comparative evolutionary analyses across fungal species

• Use structural prediction tools like AlphaFold to generate hypotheses about potential binding partners

These approaches may reveal subtle phenotypes or functional relationships not apparent in standard knockout studies .

• How can I distinguish between specific and non-specific binding when using YHR175W-A antibody?

Distinguishing between specific and non-specific binding when using YHR175W-A antibody requires multiple validation approaches:

• Perform side-by-side comparisons between wild-type and YHR175W-A knockout samples—specific signals should be absent in knockout samples

• Conduct peptide competition assays where pre-incubation with recombinant YHR175W-A should eliminate specific signals

• Use multiple antibodies targeting different epitopes of YHR175W-A; consistent staining patterns suggest specificity

• Verify that the detected band is at the expected molecular weight (5.7 kDa)

• Use quantitative approaches like dilution series to confirm that signal intensity correlates with protein concentration

• Include secondary antibody-only controls to identify background signals

• Confirm results using orthogonal methods like mass spectrometry

Recent studies have shown that genetic validation using knockout samples is superior to other types of controls, particularly for Western blots and immunofluorescence imaging .

• What are the best experimental controls for YHR175W-A antibody in different applications?

For all applications, document antibody lot numbers to address potential batch variability (<10% reported for some commercial antibodies). The YCharOS initiative has demonstrated that for Western blot applications, genetic validation with knockout samples provides the most reliable specificity control .

• How should I address potential cross-reactivity with YHR175W-A paralogs or homologs?

Although YHR175W-A antibody reportedly shows no cross-reactivity with S. cerevisiae paralogs (e.g., YHR213W-A, YHR214C-E), cross-reactivity remains a significant concern in antibody-based research . To address this:

• Perform sequence alignment of YHR175W-A with potential cross-reactive proteins

• Test the antibody against recombinant versions of related proteins

• Include samples from knockout strains lacking the target protein

• Use peptide competition with both target and potential cross-reactive peptides

• Consider orthogonal methods like mass spectrometry to identify actual binding targets

• Be particularly cautious when using the antibody in new species or cell types

Recent studies have highlighted that cross-reactivity is a pervasive problem in antibody-based research, with an estimated 50% of commercial antibodies failing to meet basic standards for characterization .